The COVID-19 pandemic has further emphasized the need for specialty nurses who understand how to care for patients with chronic diseases. The demand for these caregivers is only going to intensify in coming years as healthcare delivery evolves and becomes even more complex. It has now been a century since the discovery of insulin, a...
Chinese people are more likely to face high blood pressure and other health risks as a result of higher body mass index (BMI) and waist circumference than people from other racial and ethnic groups, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Over 2.1 billion adults are estimated to have...
For the sixth year running, Endocrine News talks to editors from Endocrine Society publications to get the scoop on the top endocrine discoveries of 2020. In this fourth installment, we talk to The Journal of Clinical Endocrinology & Metabolism editors about what they think this year’s most significant studies were that will impact endocrine science...
For the sixth year running, Endocrine News talks to editors from Endocrine Society publications to get the scoop on the top endocrine discoveries of 2020. In this third installment, we talk to Journal of the Endocrine Society editors about what they think this year’s most significant studies were that will impact endocrine science for years...
Machine learning, a form of artificial intelligence, can predict which women are at high risk of developing gestational diabetes and lead to earlier intervention, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Gestational diabetes is a common complication during pregnancy that affects up to 15% of pregnant women. High...
For the sixth year running, Endocrine News talks to editors from Endocrine Society publications to get the scoop on the top endocrine discoveries of 2020. In this second installment, we talk to Endocrine Reviews editors about what they think this year’s most significant studies were that will impact endocrine science for years to come. Despite...
[Editor’s note: This post has been updated to clarify that the meta-analysis published in Diabetologia and the Phase IIb trial were separate studies.] Earlier this fall, Phase IIb topline results of the DIAGNODE-2 trial demonstrated a potential type 1 diabetes vaccine GAD-alum — an immunomodulating antigen-specific therapy – had a highly significant and clinically relevant...
For the sixth year running, Endocrine News talks to editors from Endocrine Society publications to get the scoop on the top endocrine discoveries of 2020. In this first installment, we talk to Endocrinology editors about what they think this year’s most significant studies were that will impact endocrine science for years to come. Despite the...